News
UnitedHealth stock is deeply oversold, undervalued, and primed for a recovery. Read why analysts forecast UNH to have a ~29% ...
In legal letters and court filings, UnitedHealth has cited Thompson’s murder to argue that criticizing the company could lead ...
These compounding challenges have dampened investor sentiment and even sparked questions about UnitedHealth’s continued inclusion in the prestigious Dow Jones Industrial Average.
StockStory.org on MSN37m
Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To KnowA number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector.
UnitedHealth Group remains a dominant force within the U.S. healthcare landscape, with a market capitalization of $272.7 billion. The company operates through its two primary arms, UnitedHealthcare ...
Investors with a lot of money to spend have taken a bearish stance on UnitedHealth Group (NYSE:UNH). And retail traders should know. We noticed this today when the trades showed up on publicly ...
UnitedHealth, Centene, and Elevance suffered steep market cap losses amid earnings guidance withdrawals and potential Medicaid changes tied to new legislation.
Health Insurance Giant’s Changing Fortunes UnitedHealth Group (NYSE:UNH) is the largest U.S. health insurer by market cap and ...
StockStory.org on MSN37m
QuidelOrtho, Acadia Healthcare, Elevance Health, Molina Healthcare, and Alignment Healthcare Stocks Trade Down, What You Need To KnowWhat Happened? A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the ...
Comparing UnitedHealth Group's Short Interest Against Its Peers Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing.
US Stock futures rise slightly after a weak tech-led start to the second half of 2025, offering signs of investor caution but ...
StockStory.org on MSN2d
Why Lantheus (LNTH) Stock Is Down TodayShares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell 7.7% in the morning session after the stock hit a new 52-week low amid persistent investor concerns over rising competition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results